NIH: Office of Disease Prevention

Menu
Robert S. Gordon Jr. Lecture in Epidemiology
Year Speaker and Lecture Details
2016 Michael Bracken, Ph.D., M.P.H., F.A.C.E. External Website Policy Yale School of Public Health
Inefficiency and Waste in Biomedical Research: How Prevalent Is It, What Are Its Causes, and How Is It Prevented?
2015 Shiriki K. Kumanyika, Ph.D., M.P.H. External Website Policy Perelman School of Medicine at the University of Pennsylvania, Bethesda
Research Directions for Solving the Obesity Epidemic in High-Risk Populations
2014 Moyses Szklo, M.D., Dr.P.H., M.P.H. External Website Policy Johns Hopkins University Bloomberg School of Public Health, Baltimore
Epidemiology: Back to Translation (PDF - 370 KB)
Watch an NIH videocast of this seminar.
2013 Mitchell Gail, M.D., Ph.D. Division of Cancer Epidemiology & Genetics, National Cancer Institute
Using Risk Models for Breast Cancer Prevention (PDF - 476KB)
Watch an NIH videocast of this seminar
2012 Lewis H. Kuller, M.D., Dr.P.H., University of Pittsburgh Graduate School of Public Health
The Obesity Epidemic: Why Have We Failed? (PDF - 234KB)
Watch an NIH videocast of this seminar
2011 Jonathan Samet, M.D., Johns Hopkins University Bloomberg School of Public Health, Baltimore
Big Epidemiology for Big Problems
2010 Julie E. Buring, Sc.D., Harvard Medical School, Boston
What Do We Do When Studies Disagree?
2009 Leon Gordis, M.D., Dr.P.H., M.P.H., Johns Hopkins University, Baltimore
Epidemiology at the Interface of Science, Policy, and Politics: Are New Directions Needed for Epidemiology Training Today?
2008 Alice S. Whittemore, Ph.D., Stanford University School of Medicine, California
Personalizing Cancer Prevention
2007 Robert N. Hoover, M.D., Sc.D., The National Cancer Institute, NIH
Hormones & Breast Cancer: Etiology vs. Ideology
2006 Steven N. Blair, P.E.D., The Cooper Institute, Texas
Physical Inactivity: The Biggest Public Health Problem in the 21st Century
2005 Jo Ann Manson, M.D., Dr.P.H., Harvard Medical School, Boston
Post-Menopausal: Can Divergent Findings from Clinical Trials and Observational Studies Be Reconciled?
2004 Elizabeth Barrett-Connor, M.D., University of California, San Diego
Diversity, Body Size and Diabetes: Genetics Without Genotyping
2003 Jeremiah Stamler, M.D., Northwestern University
Nutrition, Blood Pressure, Cholesterol and Low Risk
2002 Sir Richard Peto, F.R.S., University of Oxford, UK
Halving Premature Death
2001 David L. DeMets, Ph.D., University of Wisconsin, Madison
Managing and Monitoring Multicenter Clinical Trials: Who Is in Charge of What?
2000 Steven R. Cummings, M.D., FACP, University of California, San Francisco
New Technology and a Two-Edged Sword: How Bone Densitometry Has Revolutionized and Impeded the Understanding and Prevention of Osteoporotic Fractures
1999 Walter C. Willett, M.D., Dr.P.H., Harvard Medical School, Boston
Diet and Coronary Heart Disease: Have We Misled the Nation?
1998 Alfred Sommer, M.D., M.H.S., Johns Hopkins University School of Hygiene and Public Health, Baltimore
Epidemiology in the Cause of Vitamin A: Science to Practice
1997 Jean W. MacCluer, Ph.D., University of Texas Health Science Center, San Antonio
From Epidemiology to Gene Discovery: Finding Genes for Complex Diseases
1996 Joseph F. Fraumeni, Jr., M.D., Sc.M., Director, Division of Cancer Epidemiology and Genetics, National Cancer Institute
Epidemiology of Cancer: An Interdisciplinary Approach
1995 Charles H. Hennekens, M.D., Dr.P.H., John Snow Professor of Medicine and Ambulatory Care and Prevention, Harvard Medical School
Aspirin in the Secondary and Primary Prevention of Cardiovascular Disease